000 01630 a2200397 4500
005 20250514031925.0
264 0 _c20020516
008 200205s 0 0 eng d
022 _a1537-6591
024 7 _a10.1086/339866
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSavès, Marianne
245 0 0 _aFactors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cMay 2002
300 _a1396-405 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiretroviral Therapy, Highly Active
_xadverse effects
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCohort Studies
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aHypertriglyceridemia
_xetiology
650 0 4 _aLipodystrophy
_xetiology
650 0 4 _aRitonavir
_xadverse effects
650 0 4 _aStavudine
_xadverse effects
700 1 _aRaffi, François
700 1 _aCapeau, Jacqueline
700 1 _aRozenbaum, Willy
700 1 _aRagnaud, Jean-Marie
700 1 _aPerronne, Christian
700 1 _aBasdevant, Arnaud
700 1 _aLeport, Catherine
700 1 _aChêne, Geneviève
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 34
_gno. 10
_gp. 1396-405
856 4 0 _uhttps://doi.org/10.1086/339866
_zAvailable from publisher's website
999 _c11882078
_d11882078